Timothy Patrick Lynch
Director of Investments at Stonepine Capital Management LLC
Net worth: 253 655 $ as of 2024-04-29
Profile
Mr. Timothy P.
Lynch is a Managing Member at Stonepine Capital Management LLC.
Previously he served as Chief Financial Officer at Tercica, Inc. and InterMune, Inc. He also worked in corporate development for Elan Corporation plc and began his career with Goldman, Sachs & Co. He has served on the Boards of Directors of Aradigm Corporation, Allos Therapeutics, Bioform Medical, Insite Vision, and Nabi Biopharmaceuticals.
He has also served as a member of the Cowen Healthcare Royalty Fund’s strategic advisory board.
Mr. Lynch is a graduate of Colgate University and Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2022-12-30 | 100,259 ( 0.26% ) | 253 655 $ | 2024-04-29 |
Timothy Patrick Lynch active positions
| Companies | Position | Start |
|---|---|---|
Stonepine Capital Management LLC
 Stonepine Capital Management LLC Investment ManagersFinance Stonepine Capital Management LLC (Stonepine) is an independent registered investment advisor and hedge fund manager headquartered in Bend, Oregon. The firm was founded by Jon M. Plexico in 2006. Stonepine serves as the general partner and investment adviser to a private investment fund. | Director of Investments | 2007-12-31 |
Former positions of Timothy Patrick Lynch
| Companies | Position | End |
|---|---|---|
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Director/Board Member | 2011-12-30 |
| INSITE VISION INC. | Director/Board Member | 2011-09-15 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Director/Board Member | 2009-06-03 |
BioForm Medical, Inc.
 BioForm Medical, Inc. Medical SpecialtiesHealth Technology BioForm Medical, Inc. is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient's appearance. Their core product is Radiesse dermal filler, an injectable dermal filler designed to provide aesthetic improvement for patients. The company also offers Radiesse Voice and Radiesse Voice Gel for vocal fold insufficiency and Coaptite as a treatment for women who have stress urinary incontinence. BioForm Medical was founded in 1999 and is headquartered in San Mateo, CA. | Director/Board Member | 2010-02-18 |
| ARADIGM CORPORATION | Director/Board Member | 2009-02-16 |
Training of Timothy Patrick Lynch
| Colgate University | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
BioForm Medical, Inc.
BioForm Medical, Inc. Medical SpecialtiesHealth Technology BioForm Medical, Inc. is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient's appearance. Their core product is Radiesse dermal filler, an injectable dermal filler designed to provide aesthetic improvement for patients. The company also offers Radiesse Voice and Radiesse Voice Gel for vocal fold insufficiency and Coaptite as a treatment for women who have stress urinary incontinence. BioForm Medical was founded in 1999 and is headquartered in San Mateo, CA. | Health Technology |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
| Neurostat Pharmaceuticals, Inc. | |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology InSite Vision Inc. develops and markets ophthalmic pharmaceutical products that designs to treat a range of common eye problems, including ocular infection, pain and inflammation in ocular surgery, and glaucoma. Its products include AzaSite, Besivance, AzaSite Plus, DexaSite, AzaSite Xtra, and ISV-10 and 303. The company was founded by Merwin Jerry Hansen in 1986 and is headquartered in Alameda, CA. | Health Technology |
Stonepine Capital Management LLC
Stonepine Capital Management LLC Investment ManagersFinance Stonepine Capital Management LLC (Stonepine) is an independent registered investment advisor and hedge fund manager headquartered in Bend, Oregon. The firm was founded by Jon M. Plexico in 2006. Stonepine serves as the general partner and investment adviser to a private investment fund. | Finance |
| Vivo Therapeutics, Inc. | |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
ClearFlow, Inc.
 ClearFlow, Inc. Medical SpecialtiesHealth Technology ClearFlow, Inc. develops surgical and medical devices. Its products are based on proprietary tube clearance technologies to resolve catheter clogging in other medical market segments, including urinary catheters, gastrointestinal catheters, and wound drainage. The company was founded by Andrew D. Firlik, Marc A. Gillinov and Edward M. Boyle Jr. in 2006 and is headquartered in Irvine, CA. | Health Technology |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Timothy Patrick Lynch
